Search Orphan Drug Designations and Approvals
-
Generic Name: | sodium 4-{ [9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-d] [2] benzazepin-2-yl]-2-methoxybenzoate |
---|---|
Date Designated: | 04/03/2009 |
Orphan Designation: | Treatment of ovarian cancer |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 06/14/2016 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-